hepatitis B – Medxy AI

PegIFN Alpha-2a Therapy Reduces Relapse Risk after NUC Discontinuation in HBeAg-Negative Chronic Hepatitis B: Insights from a Randomized Controlled Trial

By MedXY 09/21/2025

Switching from nucleo(s)tide analogues to pegylated interferon alpha-2a significantly lowers virological relapse and boosts HBsAg clearance in HBeAg-negative chronic hepatitis B patients after treatment cessation.

Gastroenterology news Specialties

Enhanced Diagnostic and Prognostic Utility of the China-CLIF Framework for Acute-on-Chronic Liver Failure Across Diverse Aetiologies

By MedXY 09/04/2025

A large multicohort study demonstrates that the China-CLIF framework outperforms existing criteria in diagnosing and predicting mortality in acute-on-chronic liver failure across all major aetiologies, with global applicability.

Gastroenterology news Oncology Specialties

From Silent Struggles to Serious Threats: Understanding Your Liver’s Journey from Hepatitis to Cancer

By MedXY 09/03/2025

Explore how subtle liver symptoms can signal serious illness, the progression from hepatitis to liver cancer, and effective habits to protect your liver health.